PharmExec

DECEMBER 8, 2022

Our annual report spotlighting notable investments in new drug development captures a mix of gradual gains and giant leaps—both equally as promising—in five expanding and diverse therapeutic areas: spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics.

119

119

Pharmaceutical Technology

FEBRUARY 10, 2023

4DMT has stated that it will examine the 12 months of data from the Phase I/II trial on six patients in H2 2023 with the clinical hold not expected to have any additional impact on the company’s Phase III plans.

FDA 105

FDA Competition Leads Marketing 105

Spotio

MAY 8, 2023

Then, we’ll highlight what key features to look out for as we review the best sales forecasting software for you to consider in 2023. Forecast reports compare sales targets with achieved sales versus expected sales. Looking for the best sales forecasting software? Why is Sales Forecasting Software Important for Your Business?

Sales 52

Sales Sales pipeline Sales goal CRM 52

European Pharmaceutical Review

SEPTEMBER 20, 2023

The presence of novel and increasingly complex molecules in today’s pipelines requires analytical methods with higher resolution, throughput and sensitivity. Development paths have been reported to be further accelerated in response to the COVID-19 pandemic, with the potential to reduce gene to IND timelines to only six months.

Patients 84

Patients Manufacturing Leads Safety 84

Pharmaceutical Technology

JUNE 22, 2023

The European Commission’s (EC) plan to test a novel scheme to incentivise antimicrobial drug development companies remains beset by questions amidst the bloc’s drive to tackle the growing threat of antimicrobial resistance (AMR). Hence, some experts remain unsure of how the scheme will incentivise the development of new drugs to fight AMR.

Pharma 52

Pharma Pharmaceutical Government Marketing 52